178 related articles for article (PubMed ID: 7694170)
21. Effects of the antidepressant drug tianeptine on plasma and platelet serotonin concentrations in the rat.
Ortiz J; Mocaër E; Artigas F
Eur J Pharmacol; 1991 Jul; 199(3):335-9. PubMed ID: 1717295
[TBL] [Abstract][Full Text] [Related]
22. Stress and antidepressant effects on hippocampal and cortical 5-HT1A and 5-HT2 receptors and transport sites for serotonin.
Watanabe Y; Sakai RR; McEwen BS; Mendelson S
Brain Res; 1993 Jun; 615(1):87-94. PubMed ID: 8364729
[TBL] [Abstract][Full Text] [Related]
23. Effects of chronic mianserin administration on serotonin metabolism and receptors in the 5-hydroxytryptophan depression model.
Akiyoshi J; Tsuchiyama K; Mizobe Y; Nakamura M; Kuranaga H; Nagayama H
Prog Neuropsychopharmacol Biol Psychiatry; 1994 Jan; 18(1):165-79. PubMed ID: 7509496
[TBL] [Abstract][Full Text] [Related]
24. Effects of tianeptine on 5-hydroxyindoles and on the morphine-induced increase in 5-HT metabolism at the medullary dorsal horn level as measured by in vivo voltammetry in freely moving rats.
Puig S; Rivot JP; Besson JM
Brain Res; 1993 Jan; 600(2):219-24. PubMed ID: 7679603
[TBL] [Abstract][Full Text] [Related]
25. Pharmacological antidepressive effects and tianeptine-induced 5-HT uptake increase.
Mocaër E; Rettori MC; Kamoun A
Clin Neuropharmacol; 1988; 11 Suppl 2():S32-42. PubMed ID: 3180116
[TBL] [Abstract][Full Text] [Related]
26. Activation and desensitization by cyclic antidepressant drugs of alpha2-autoreceptors, alpha2-heteroreceptors and 5-HT1A-autoreceptors regulating monamine synthesis in the rat brain in vivo.
Esteban S; Lladó J; Sastre-Coll A; García-Sevilla JA
Naunyn Schmiedebergs Arch Pharmacol; 1999 Aug; 360(2):135-43. PubMed ID: 10494882
[TBL] [Abstract][Full Text] [Related]
27. Single administration of 5-HT1A agonists decreases 5-HT1A presynaptic, but not postsynaptic receptor-mediated responses: relationship to antidepressant-like action.
Kennett GA; Marcou M; Dourish CT; Curzon G
Eur J Pharmacol; 1987 Jun; 138(1):53-60. PubMed ID: 2442002
[TBL] [Abstract][Full Text] [Related]
28. Effect of acute and prolonged tianeptine administration on the 5-HT transporter: electrophysiological, biochemical and radioligand binding studies in the rat brain.
Piñeyro G; Deveault L; Blier P; Dennis T; de Montigny C
Naunyn Schmiedebergs Arch Pharmacol; 1995 Feb; 351(2):111-8. PubMed ID: 7770093
[TBL] [Abstract][Full Text] [Related]
29. A single dose of 8-OH-DPAT reduces raphe binding of [3H]8-OH-DPAT and increases the effect of raphe stimulation on 5-HT metabolism.
Beer M; Kennett GA; Curzon G
Eur J Pharmacol; 1990 Mar; 178(2):179-87. PubMed ID: 1691712
[TBL] [Abstract][Full Text] [Related]
30. The effect of the novel antidepressant tianeptine on the concentration of 5-hydroxytryptamine in rat hippocampal dialysates in vivo.
Whitton PS; Sarna GS; O'Connell MT; Curzon G
Neuropharmacology; 1991 Jan; 30(1):1-4. PubMed ID: 2046875
[TBL] [Abstract][Full Text] [Related]
31. Serotonin uptake inhibition: in vivo effect of sertraline in rats.
Manfridi A; Clavenna A; De Simoni MG
Neurosci Lett; 1992 May; 139(1):69-72. PubMed ID: 1383885
[TBL] [Abstract][Full Text] [Related]
32. [Serotonergic mechanisms in hippocampal kindled seizures--inhibitory effects of L-5-hydroxytryptophan and 8-hydroxy-2-(di-n-propylamino)tetralin].
Nakamura M; Wada Y; Hasegawa H; Yamaguchi N
No To Shinkei; 1992 Nov; 44(11):989-93. PubMed ID: 1296723
[TBL] [Abstract][Full Text] [Related]
33. Pharmacology of the novel 5-hydroxytryptamine1A receptor antagonist (S)-5-fluoro-8-hydroxy-2-(dipropylamino)tetralin: inhibition of (R)-8-hydroxy-2-(dipropylamino)tetralin-induced effects.
Björk L; Cornfield LJ; Nelson DL; Hillver SE; Andén NE; Lewander T; Hacksell U
J Pharmacol Exp Ther; 1991 Jul; 258(1):58-65. PubMed ID: 1830099
[TBL] [Abstract][Full Text] [Related]
34. (-)-Penbutolol as a blocker of central 5-HT1A receptor-mediated responses.
Hjorth S
Eur J Pharmacol; 1992 Nov; 222(1):121-7. PubMed ID: 1468487
[TBL] [Abstract][Full Text] [Related]
35. Tianeptine treatment induces regionally specific changes in monoamines.
Frankfurt M; McKittrick CR; McEwen BS; Luine VN
Brain Res; 1995 Oct; 696(1-2):1-6. PubMed ID: 8574656
[TBL] [Abstract][Full Text] [Related]
36. (R)- and (S)-8-acetyl-2-(dipropylamino)tetralin (LY-41): two novel 5-HT1A receptor agonists.
Yu H; Liu Y; Hacksell U; Lewander T
Eur J Pharmacol; 1993 Jan; 231(1):69-76. PubMed ID: 8444282
[TBL] [Abstract][Full Text] [Related]
37. Neurochemical and pharmacological properties of tianeptine, a novel antidepressant.
Labrid C; Mocaër E; Kamoun A
Br J Psychiatry Suppl; 1992 Feb; (15):56-60. PubMed ID: 1389023
[TBL] [Abstract][Full Text] [Related]
38. 4-(2'-Methoxyphenyl)-1-[2'-[N-(2"-pyridinyl)-p-iodobenzamido]ethyl] piperazine and 4-(2'-methoxyphenyl)-1-[2'-[N-(2"-pyridinyl)-p- fluorobenzamido]ethyl]piperazine, two new antagonists at pre- and postsynaptic serotonin-1A receptors.
Thielen RJ; Fangon NB; Frazer A
J Pharmacol Exp Ther; 1996 May; 277(2):661-70. PubMed ID: 8627543
[TBL] [Abstract][Full Text] [Related]
39. Further investigation of the in vivo pharmacological properties of the putative 5-HT1A antagonist, BMY 7378.
Sharp T; Backus LI; Hjorth S; Bramwell SR; Grahame-Smith DG
Eur J Pharmacol; 1990 Feb; 176(3):331-40. PubMed ID: 1970304
[TBL] [Abstract][Full Text] [Related]
40. The pharmacological profile of (R)-3,4-dihydro-N-isopropyl-3-(N-isopropyl-N-propylamino)-2H-1-benzopyran-5-carboxamide, a selective 5-hydroxytryptamine(1A) receptor agonist.
Rënyi L; Evenden JL; Fowler CJ; Jerning E; Kelder D; Lake-Bakaar D; Larsson LG; Mohell N; Sällemark M; Ross SB
J Pharmacol Exp Ther; 2001 Dec; 299(3):883-93. PubMed ID: 11714872
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
